Tech Company Financing Transactions

CSA Medical Funding Round

On 10/10/2018, CSA Medical raised $23 million in funding from Ascension Ventures, Horizon Technology Finance and Intersouth Partners.

Transaction Overview

Company Name
CSA Medical
Announced On
10/10/2018
Transaction Type
Debt
Venture Equity
Amount
$23,000,000
Round
Undisclosed
Investors

Ascension Ventures (Tara Butler)

Horizon Technology Finance

Intersouth Partners (Rick Kent)

SV Health Investors (Paul LaViolette)

Proceeds Purpose
The company will use the financing proceeds to fuel growth and expansion of its commercial truFreeze product line in the gastrointestinal (GI) market and to advance its COPD therapy, Rejuvenair, toward major clinical and regulatory approval milestones.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
91 Hartwell Ave.
Lexington, MA 02421
USA
Phone
(781) 538-4720
Website
www.csamedical.com
Email Address
[email protected]
Overview
Our truFreeze spray cryotherapy technology uses extremely cold liquid nitrogen (-196° C) to provide targeted, touchless ablation of unwanted tissue inside the body under direct visualization. The truFreeze System can be used in general surgery with or without an endoscope.
Profile
CSA Medical LinkedIn Company Profile
Social Media
CSA Medical Company Twitter Account
Company News
CSA Medical News
Facebook
CSA Medical on Facebook
YouTube
CSA Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ellen Sheets
  Ellen Sheets LinkedIn Profile  Ellen Sheets Twitter Account  Ellen Sheets News  Ellen Sheets on Facebook
VP - Engineering
John O'Connor
  John O'Connor LinkedIn Profile  John O'Connor Twitter Account  John O'Connor News  John O'Connor on Facebook
VP - Marketing
Teresa Prego
  Teresa Prego LinkedIn Profile  Teresa Prego Twitter Account  Teresa Prego News  Teresa Prego on Facebook
VP - R & D
Brian Hanley
  Brian Hanley LinkedIn Profile  Brian Hanley Twitter Account  Brian Hanley News  Brian Hanley on Facebook
VP - R & D
Ann Murphy-Legg
  Ann Murphy-Legg LinkedIn Profile  Ann Murphy-Legg Twitter Account  Ann Murphy-Legg News  Ann Murphy-Legg on Facebook
VP - Regulatory Affairs
Sherrie Coval-Goldsmith
  Sherrie Coval-Goldsmith LinkedIn Profile  Sherrie Coval-Goldsmith Twitter Account  Sherrie Coval-Goldsmith News  Sherrie Coval-Goldsmith on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/10/2018: Oblong Industries venture capital transaction
Next: 10/10/2018: Oblong Industries venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.